Search clinical trials for: Octreotide, 30 mg i.m. LAR formulation
Total 22 results
-
NovartisTerminated
-
Azidus BrasilSuspended
-
Cedars-Sinai Medical CenterNovartis PharmaceuticalsCompleted
-
Ambrilia Biopharma, Inc.CompletedAcromegalyBelarus, Hungary, Romania, Serbia, Slovakia, Ukraine
-
Peking UniversityUnknownEsophageal Neuroendocrine Carcinoma | Gastro-entero-pancreatic CarcinomaChina
-
Novartis PharmaceuticalsCompleted
-
Cerevel Therapeutics, LLCCompleted
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
Federico II UniversityOspedali dei ColliCompletedAdvanced Hepatocellular CarcinomaItaly
-
Chemi S.p.A.Completed
-
Novartis PharmaceuticalsCompletedCushing's DiseaseItaly, Belgium, Japan, Germany, United Kingdom, Thailand, Spain, France, Netherlands, Turkey, Israel, China, United States, Canada, India, Argentina, Brazil, Peru, Poland, Russian Federation
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)CompletedElectronic CigarettesUnited States
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)TerminatedElectronic CigarettesUnited States
-
Clovis Oncology, Inc.CompletedAdvanced Solid TumorNetherlands
-
RayzeBio, Inc.Active, not recruitingNeuroendocrine Tumors | Carcinoid Tumor | Gastroenteropancreatic Neuroendocrine Tumor | Carcinoid | GEP-NET | Gastroenteropancreatic Neuroendocrine Tumor Disease | Pancreatic NETCanada, Spain, United States, Netherlands, Belgium, France, Brazil
-
PfizerCompleted
-
ViiV HealthcareCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States
-
Jennifer KeiserVector Borne & Neglected Tropical Disease Control Division, Ministry of Health...Completed
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, Canada
-
Repros Therapeutics Inc.CompletedDrug InteractionsUnited States
-
Edward KasaraskisCompletedFamilial Amyotrophic Lateral SclerosisUnited States
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States